P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: A non-viral intravesical gene therapy for BCG-unresponsive NMIBC with CIS, with or without papillary disease: pivotal phase 2 interim results of detalimogene voraplasmid

P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: A non-viral intravesical gene therapy for BCG-unresponsive NMIBC with CIS, with or without papillary disease: pivotal phase 2 interim results of detalimogene voraplasmid

Friday, May 15, 2026 10:40 AM to 10:50 AM · 10 min. (America/New_York)
Hall D
Detail

Registered attendees

Eila Skinner
Eila Skinner
Professor, Department of Urology, Stanford UniversityStanford University Department of Urology
Eugene Pietzak
Eugene Pietzak
Urologic OncologistMemorial Sloan Kettering Cancer Center
Eva Bolton
Eva Bolton
UrologistImperial College

Log in

See all the content and easy-to-use features by logging in or registering!